Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 2-adamantylurea derivatives as selective 11beta-HSD1 inhibitors

2-adamantylurea derivatives as selective 11beta-HSD1 inhibitors

US Patent 8188288 · Granted May 29, 2012

Estimated economic value: $53,466,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Monoclonal antibody directed to FGFR12023
Use of tryptophan metabolites for treating muscle atrophy2022
Methods for generating bispecific shark variable antibody domains and use thereo2021
Derivatives of indole for the treatment of cancer, viral infections and lung dis2020
Biological materials related to HER32020
Methods for non-covalent Fc-domain-containing protein display on the surface of 2020
Furane derivatives as inhibitors of ATAD22020
Derivatives used in the treatment of muscle atrophy2019
Bicyclic lipolantipeptide, preparation and use as antimicrobial agent2019
Derivatives of indole for the treatment of cancer, viral infections and lung dis2019
Anti-TNFα antibodies with pH-dependent antigen binding for improved target clear2019
Method of producing secretable antibodies by expression in saccharomyces cerevis2018